Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is an open-label phase1 study to assess the safety and efficacy of U01(ssCART-19) cell therapy in the treatment of patients with refractory or recurrent B-cell lymphoma .
Epistemonikos ID: 4effc2e203b6125f8acb3dc296bf371bfda12eed
First added on: May 24, 2025